In response to the COVID-19 pandemic, UHS’ board approved base salary reductions for the company’s top executives on June 1. UHS Chair and CEO Alan Miller’s base salary will be reduced by 100 percent from June 1 through July 31, according to a filing with the Securities and Exchange Commission. The base salaries for several other UHS executives, nonexecutive officers and senior managers will be reduced between 5 percent and 20 percent between June 1 and Aug. 31.
UHS said it will contribute the funds generated from the base salary reductions to the UHS Foundation, an employee assistance program. The foundation intends to evaluate the hardships caused by the pandemic on certain UHS employees and their families and to disburse funds to those most in need of financial assistance, according to the SEC filing.
More articles on compensation:
What 20 healthcare CEOs earned in 2019
Physician compensation grew most for these 5 specialties
10 lowest-paying states for nurse practitioners
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
